Nomura Holdings Inc. Invests $447,000 in Revvity, Inc. (NYSE:RVTY)

Nomura Holdings Inc. acquired a new position in Revvity, Inc. (NYSE:RVTY - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 4,007 shares of the company's stock, valued at approximately $447,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Quarry LP grew its position in shares of Revvity by 45.7% in the 4th quarter. Quarry LP now owns 303 shares of the company's stock worth $34,000 after buying an additional 95 shares during the period. HB Wealth Management LLC grew its position in shares of Revvity by 4.6% in the 4th quarter. HB Wealth Management LLC now owns 2,380 shares of the company's stock worth $266,000 after buying an additional 104 shares during the period. Signaturefd LLC grew its position in shares of Revvity by 6.8% in the 4th quarter. Signaturefd LLC now owns 1,668 shares of the company's stock worth $186,000 after buying an additional 106 shares during the period. Westside Investment Management Inc. grew its position in shares of Revvity by 0.8% in the 4th quarter. Westside Investment Management Inc. now owns 14,363 shares of the company's stock worth $1,603,000 after buying an additional 108 shares during the period. Finally, EverSource Wealth Advisors LLC grew its position in shares of Revvity by 33.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 522 shares of the company's stock worth $58,000 after buying an additional 131 shares during the period. 86.65% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. JPMorgan Chase & Co. reduced their target price on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 29th. The Goldman Sachs Group reduced their target price on shares of Revvity from $140.00 to $125.00 and set a "buy" rating on the stock in a research report on Tuesday, April 29th. Raymond James reissued an "outperform" rating and set a $120.00 price objective (down from $145.00) on shares of Revvity in a research report on Tuesday, April 29th. KeyCorp raised their price objective on shares of Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. Finally, UBS Group upgraded shares of Revvity from a "neutral" rating to a "buy" rating and reduced their price objective for the company from $145.00 to $115.00 in a research note on Thursday, May 1st. Five investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Revvity presently has a consensus rating of "Moderate Buy" and an average target price of $125.64.

Revvity Stock Performance

Shares of RVTY stock traded up $2.89 during trading hours on Tuesday, reaching $92.22. The company had a trading volume of 1,536,455 shares, compared to its average volume of 953,932. The business has a fifty day moving average price of $96.00 and a 200-day moving average price of $108.76. Revvity, Inc. has a one year low of $88.01 and a one year high of $129.50. The firm has a market cap of $10.87 billion, a PE ratio of 41.73, a price-to-earnings-growth ratio of 3.82 and a beta of 1.02. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.03 and a current ratio of 3.60.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings results on Monday, April 28th. The company reported $1.01 EPS for the quarter, topping analysts' consensus estimates of $0.96 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. The firm had revenue of $664.76 million during the quarter, compared to analyst estimates of $662.30 million. During the same period in the previous year, the business posted $0.98 earnings per share. The business's revenue for the quarter was up 2.3% on a year-over-year basis. Sell-side analysts predict that Revvity, Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be paid a $0.07 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.30%. Revvity's dividend payout ratio is presently 11.91%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.